Oblikovanje in razvoj spletne strani: Studio N.
© 2024 SZGH ⋅ Vse pravice pridržane.
I am pleased to extend an invitation to the Sixth Congress of the Slovenian Society of Gastroenterology and Hepatology. The congress will be held at the Austria Trend Hotel Ljubljana from June 6th to 7th, 2025.
The congress will feature participation from colleagues representing over 20 countries.
Gastrointestinal diseases represent a major burden on the population and the health system. The proportion of patients with gastrointestinal diseases is constantly increasing, not only due to the aging of the population, but also the way of life nowadays. Progress with new findings, development of new therapeutic approaches, new diagnostic methods contribute to a better treatment outcome, but at the same time they pose additional challenges. Research in many areas of gastroenterology and hepatology continues to progress rapidly.
The key for us clinics is to follow this and integrate innovations into our daily work in a timely manner, because only in this way will we be able to offer superior and sufficiently high-quality treatment to our patients.
The meeting will showcase innovations in gastroenterology, including IBD, lower and upper gastrointestinal tract diseases, liver, pancreas, endoscopy, imaging diagnostics, pathology, and surgery.
A dedicated section will explore the current and future role of artificial intelligence in the field.
Preceding the congress, the Central European Gastroenterology Forum will take place on June 5th, 2025. The forum will facilitate discussions on treatment quality, diverse practices across different settings, and strategies for harmonizing and elevating standards of care. It also seeks to foster collaboration within the Central European region.
The congress is intended for physicians in GI/hepatology, abdominal surgery, radiology, oncology, pathology, general medicine, and medical technicians.
The Slovenian Association of Medical Technicians will also hold a parallel professional meeting in GI endoscopy.
We would also like to invite abstract submissions for poster presentations. Posters should present original research, clinical cases, or innovative practices in gastroenterology and hepatology. Abstract submissions will be accepted until April 15th, 2025. Selected posters will be displayed throughout the congress, with dedicated viewing sessions scheduled during breaks.
Guidelines for poster submissions and abstract format requirements will be available on the congress website (www.szgh.si). Authors of accepted posters will be notified by May 1st, 2025.
Our meetings are supported by sponsors. Don’t miss the chance to present your company, achievements, and exchange opinions with experts passionate about improving the health and lives of people with gastrointestinal diseases.
On behalf of the organizing committee,
Milan Stefanovic M.D., AGAF
President of SAGH
Thursday at 15:00–19:00;
Friday at 7:00–19:00
| TIME | TITLE |
|---|---|
| 16:00–18:30 | Central European Gastroenterology Forum: Quality of colonoscopy with an emphasis on sedation, where are we and how to move forward? Different experiences in different countries and how to harmonize positive practice? (for the development of relationships and about possible cooperation in the field of gastroenterology and hepatology) |
| 20:00 | Faculty dinner |
| TIME | TITLE | SPEAKERS |
|---|---|---|
| 8:00–8:30 | Opening ceremony of the congress | |
| Speakers: Bojana Beović, President of the Slovenian Medical Chamber Joost Drenth, Vice President of United European Gastroenterology and President-elect Milan Stefanović, President of the Slovenian Society of Gastroenterology and Hepatology | ||
| 8:40–10:20 | 1. IBD | |
| Moderators: TBA | ||
| 08:40–08:55 | New guidelines for the treatment of Crohn's disease | Hanžel, J. |
| 08:55–09:10 | IBD remission after switching from IV to SC administration of vedolizumab | Novak, G. |
| 09:10–09:25 | Maintenance of IBD remission after switching from IV to SC administration of infliximab | Ocepek, A. |
| 09:25–09:40 | Surgical treatment of IBD | Grosek, J. |
| 09:40–09:55 | Tracing Transmural Healing in Crohn's Disease with MRI | Rudolf, S. |
| 09:55–10:10 | PICaSSO Histologic Remission Index – a new histologic score for monitoring mucosal healing and predicting clinical outcomes in UC | Zidar, N. |
| Followed by a 10-minute panel discussion | ||
| 10:20–10:40 | 1st Satellite: Intestinal US in IBD | Petersen F. |
| 10-minute Break | ||
| 10:50–13:30 | 2. Lower gastrointestinal tract I | |
| Moderators: TBA | ||
| 10:50–11:10 | AI in pT1 colorectal carcinoma | Schoon, E. |
| 11:10–11:30 | ESD east versus west | Ohata, K. |
| 11:30–11:50 | Endoscopic therapy: What can we learn from Japan/tips and tricks | Minato, Y. |
| 11:50–12:10 | ESD in the west, are we there yet? | Bhandari, P. |
| Followed by a 10-minute panel discussion | ||
| 10-minute Break | ||
| 12:20–12:35 | Watch and wait approach to the treatment of rectal carcinomas | Brecelj, E. |
| 12:35–12:50 | Response to neoadjuvant treatment of rectal adenocarcinoma: the role and potential burden of MRI in the watch and wait approach? | Garbajs, M. |
| 12:50–13:05 | Contribution of the SVIT Program to the reduction of the burden of colorectal cancer in Slovenia | Zadnik, V. |
| 13:05–13:20 | Sixteen years of the Slovenian national screening program for the early detection and prevention of colorectal cancer SVIT | Stefanović, M. |
| Followed by a 10-minute panel discussion | ||
| 13.30–14:00 | 2nd Satellite: TBA | |
| 14:00–15:00 | Lunch | |
| 15:00–16:40 | 3. HBP endoscopy | |
| Moderators: TBA | ||
| 15:00–15:15 | European cholangioscopy guidelines | Stefanović, S. |
| 15:15–15:30 | EUS guided gallbladder drainage | Hindryckx, P. |
| 15:30–15:45 | Therapeutic options in patients with surgically altered anatomy - enteroscopy-assisted or laparoscopy-assisted ERCP | Bokun, T. |
| 15:45–16:00 | ERCP complications | Djuranović, S. |
| 16:00–16:15 | Advanced percutaneous biliary procedures - what is new? | Dežman, R. |
| 16:15–16:30 | Minimal liver surgery (past, present, future) | Björn, N. |
| Followed by a 10-minute panel discussion | ||
| 16:40–17:00 | 3rd Satellite: TBA | |
| 10-minute Break | ||
| 17:10–19:05 | 4. Diseases of the liver | |
| 17:10–17:25 | Autoimmune hepatitis | Drenth, J. |
| 17:25–17:40 | US in liver disease | Grgurević, I. |
| 17:40–17:55 | Complications after liver surgery | Trotovšek, B. |
| 18:10–18:25 | Radioembolization of the liver (our experience) | Popovič, P. |
| 18:25–18:40 | Does surgical treatment of benign liver tumors affect the survival and quality of life of patients? | Ivanecz, A. |
| 18:40–18:55 | Advanced systemic therapy of hepatocellular carcinoma | Boltežar, G. |
| Followed by a 10-minute panel discussion | ||
| 20:00– | Dinner – Location TBD |
| TIME | TITLE | SPEAKERS |
|---|---|---|
| 07:00–08:30 | Interactive breakfast section In advance registration of participants. No registration fee for participants. Participation in the set is limited. | |
| Endoscopy and AI, Where are we? | ||
| Moderators: TBA | ||
| I. Role of artificial intelligence in endoscopy | ||
| II. Study results | ||
| III. Future directions | ||
| Discussion with the Panelists and Auditorium | ||
| 8:30–10:15 | 5. Nutrition, microbiota Functional disorders of digestion - diagnostics and therapy | |
| Moderators: TBA | ||
| 08:30–08:45 | Functional diseases of the gastrointestinal tract in children | Orel, R. |
| 08:45–08:50 | Twenty years of our experience in hydrogen breath tests for SIBO diagnostics | Volfand, J. |
| 08:50–09:10 | SIBO | Hammer, H. |
| 09:10–09:25 | Short bowel syndrome | Rotovnik Kozjek, N. |
| 09:25–09:45 | Gastroparesis: What is new in etiology, diagnostics, and treatment | Tack, J. |
| 09:45–10:05 | EoE: What is new in etiology, diagnostics, and treatment | Labenz, J. |
| Followed by a 10-minute panel discussion | ||
| 10:15–10:35 | 4th Satellite: TBA | |
| 15-minute Break | ||
| 10:50–12:30 | 6. Diseases of the upper gastrointestinal tract | |
| Moderators: TBA | ||
| 10:50–11:10 | IARC Expert Group Guidance on the Implementation of Population-Based Helicobacter pylori Test-and-Treat Strategies for Prevention of Gastric Cancer | Park, J. Y. |
| 11:10–11:25 | NIJZ Trends in Incidence and Survival of Patients with Gastric Cancer in Slovenia | Kofol, T. B. |
| 11:25–11:45 | The Results of H. pylori Test-and-Treat Implementation Studies in Slovenia and EU (EUROHELICAN, TOGAS WP 4 Study) | Tepeš, B. |
| 11:45–12:05 | Cost-Benefit Analysis of the National H. pylori Test-and-Treat Program in Slovenia | Vogelar, I. L. / Mulder, D. |
| 12:05–12:20 | Hereditary Diffuse Gastric Cancer: Is Prophylactic Gastrectomy Indicated for Healthy Carriers of CDH1 Gene Mutations? | Omejc, M. |
| Followed by a 10-minute panel discussion | ||
| 12:30–13:00 | 5th Satellite: TBA | |
| 13:00–14:00 | Lunch | |
| 14:00–16:10 | 7. Pancreatic diseases | |
| Moderators: TBA | ||
| 14:00–14:15 | Radiological Diagnosis and Follow-up of Pancreatic Cysts | Dežman, R. |
| 14:15–14:30 | Neuroendocrine Tumors of the Pancreas (Histo-Pathology) | Luzar, B. |
| 14:30–14:45 | Pancreatic NETs: Refining Indications Through Observation, Surgery, and Multimodal Treatment Strategies | Partelli, S. |
| 14:45–15:00 | Total Pancreatectomy – When and Why? | Potrč, S. |
| 15:00–15:15 | Clinical Evidence in MIPS | Petrič, M. |
| 15:15–15:30 | Neoadjuvant Treatment in PDAC – Only for Borderline Resectable Tumors? | Šmid, L. |
| 15:30–15:45 | Vaccines in the Treatment of Pancreatic Adenocarcinoma | Ocvirk, J. |
| 15:45–16:00 | Clinical Consequences of Autoimmune Pancreatitis | Nikolić, S. |
| Followed by a 10-minute panel discussion | ||
| 16:10–16:30 | 6th Satellite: TBA | |
| 10-minute Break | ||
| 8. Parallel lectures: A and B | ||
| 17:10–18:55 | A. Endoscopy / Surgery / Radiology / Oncology | |
| Moderators: TBA | ||
| 17:10–17:20 | Dilemmas of Surgical Treatment of Acute Diverticulitis | Janež, J. |
| 17:20–17:30 | ICG Imaging in Abdominal Surgery | Košir, J. A. |
| 17:30–17:45 | Hemorrhoids Embolization – Experimental Procedure or a New Tool in a Box | Štabuc, M. |
| 17:45–17:55 | New 2024 EASL Guidelines and Treatment of Patients at KOGE | Novak, K. |
| 17:55–18:05 | IPMN Management – Fukuoka Consensus vs. European Evidence-based Guidelines | Đokić, M. |
| 18:05–18:15 | Diagnostic Work-up of Colorectal Tumors: Carcinoma Mimickers | Šifer, K. K. |
| 18:15–18:25 | Robotic Abdominal Surgery – Past, Present, and the Future | Grosek, J. |
| 18:25–18:35 | Liver Metastases Detection and Staging with CT and MRI: Methods and Problems | Garbajs, M. |
| 18:35–18:45 | Characteristics of Cystic Fibrosis Patients in Gastroenterologist Treatment | Turk Jerovšek, M. |
| Followed by a 10-minute panel discussion | ||
| 16:40–18:00 | B. Poster session | |
| Presentation of the best three award-winning posters. | ||
| Poster selection committee: Štabuc, B., Novak, G., Tepeš, K., Ivanecz, A. | ||
| 19:00 | End of Congress |
To apply online, please fill out the form:
Payment | Participants will cover their own accommodation with breakfast, tourist tax and all additional services (mini bar, fitness, spa, parking…). Upon check-in at the hotel, participants present a credit card to pay for hotel services (bed and breakfast, tourist tax and any additional services – mini bar, fitness, spa, parking…). |
Cancellation fees | Participants can cancel their accommodation free of charge up to 7 days before arrival. In case of later cancellation or no-show, cancellation fees in the amount of the booked nights will be charged. |
Slovensko združenje za
gastroenterologijo in hepatologijo
Zdraviliški trg 9
3250 Rogaška Slatina, Slovenija
Oblikovanje in razvoj spletne strani: Studio N.
© 2024 SZGH ⋅ Vse pravice pridržane.